- Home
- XXII vs TCRT Comparison
XXII vs TCRT Comparison
Compare XXII & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- TCRT
- Stock Information
- Founded
- XXII 1998
- TCRT 1998
- Country
- XXII United States
- TCRT United States
- Employees
- XXII N/A
- TCRT N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- XXII Health Care
- TCRT Health Care
- Exchange
- XXII Nasdaq
- TCRT Nasdaq
- Market Cap
- XXII 2.1M
- TCRT 2.5M
- IPO Year
- XXII N/A
- TCRT N/A
- Fundamental
- Price
- XXII $0.80
- TCRT $2.63
- Analyst Decision
- XXII
- TCRT
- Analyst Count
- XXII 0
- TCRT 0
- Target Price
- XXII N/A
- TCRT N/A
- AVG Volume (30 Days)
- XXII 1.6M
- TCRT 1.5M
- Earning Date
- XXII 05-14-2025
- TCRT 05-14-2025
- Dividend Yield
- XXII N/A
- TCRT N/A
- EPS Growth
- XXII N/A
- TCRT N/A
- EPS
- XXII N/A
- TCRT N/A
- Revenue
- XXII $24,382,000.00
- TCRT $10,000.00
- Revenue This Year
- XXII $19.23
- TCRT $5,680,500.00
- Revenue Next Year
- XXII $81.05
- TCRT N/A
- P/E Ratio
- XXII N/A
- TCRT N/A
- Revenue Growth
- XXII N/A
- TCRT 100.00
- 52 Week Low
- XXII $0.70
- TCRT $1.31
- 52 Week High
- XXII $265.95
- TCRT $14.20
- Technical
- Relative Strength Index (RSI)
- XXII 26.33
- TCRT 54.55
- Support Level
- XXII $0.70
- TCRT $2.27
- Resistance Level
- XXII $0.83
- TCRT $2.93
- Average True Range (ATR)
- XXII 0.21
- TCRT 0.40
- MACD
- XXII 0.05
- TCRT -0.05
- Stochastic Oscillator
- XXII 5.92
- TCRT 33.04
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.